FOR SWITZERLAND ONLY
COVID-19 WORKPLACE SEROLOGICAL TEST
EASY / SAFE / FAST / ACCURATE
HemaXis DB10 drastically simplifies blood collection for
Serology WORKPLACE COVID-19 testing
As an employer, you are preparing the return to the workplace of your colleagues.
Given the difficulty to get tested, and the uncertainty whether your employees have been infected or not, we offer you the possibility to invite each employee to get a anti-body detection test at work and on an anonymous and voluntary basis.
The process is very lean and straight forward. A professional nurse collects the sample by using our patented CE marked microsmapling blood collection device in less than a minute per patient. And an accredited analytical laboratory performs the ELISA IgG COVID-19 Serological analysis.
It’s easy, safe, fast and accurate.
WHY ?
- Better understanding of the immune situation of the company’s workforce
- Reassure your employees of the safety procedures in place when coming back to their workplace
- Assess the COVID-19 action plan put in place
- Anticipate procedures and testing for a second wave
- Sampling done by a healthcare professional directly at your workplace via a simple finger prick
- Cost and time attractive, needle-free sample collection
COVID-19 WORKPLACE Serology testing
is SAFE, EASY, FAST, ACCURATE is Cost and time attractive is more reliable than rapid tests
Finger prick test
At your workplace
Samples analysed by a Swiss accredited medical laboratory
Sampling done by a trained healthcare professional
The serology test is FDA & CE-IVD approved
Positive results will be re-confirmed
What is tested ? with HemaXis DB10
When in contact with the virus, the immune system reacts by producing IgG antibodies which fight the virus.
Studies show that these antibodies are generally detected in blood after 10–14 days after the onset of the infection.
HemaXis DB10 microsampling blood collection device can be coupled to most of the ELISA kits available on the market, tests have been made on different ones, like for example the Anti-SARS-CoV-2 ELISA IgG from EUROIMMUN and are giving great performances.
These antibodies tests can be used by companies or corporation to optimally organise return to work after confinement and/or to asses the confinement plans putted in place at the start of the spread of the pandemic.
JAMA Network Viewpoint on Interpreting Diagnostic Tests for SARS-CoV-2 :
Want a quote for a Serology WORKPLACE COVID-19 Testing
Just let us know